Creating a new adjuvant to enhance influenza vaccines

DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE

NIH-funded research Scripps Institution of Oceanography · NIH-10935796

This study is testing a new ingredient called Fos47 that could help make flu vaccines work better and last longer, especially for older adults and people with ongoing health issues, before it’s tried in people.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionScripps Institution of Oceanography NIH-funded
Lab location1 site (La Jolla, UNITED STATES)
Project IDNIH-10935796 on NIH RePORTER

What this research studies

This research focuses on developing a new immune-boosting adjuvant called Fos47 to improve the effectiveness and longevity of influenza vaccines. Current vaccines often provide limited protection, especially for the elderly and those with chronic diseases, necessitating annual updates to combat new virus strains. The study will evaluate Fos47's protective efficacy in animal models and determine the best dosage, administration route, and frequency for immunization before moving to human clinical trials. This approach aims to enhance the immune response against various influenza strains.

Who could benefit from this research

Good fit: Ideal candidates for this research include elderly individuals and patients with chronic diseases who are at higher risk for influenza complications.

Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccinations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and longer-lasting influenza vaccines, particularly benefiting vulnerable populations.

How similar studies have performed: Previous research has shown promise in developing adjuvants to enhance vaccine efficacy, indicating potential success for this novel approach.

Where this research is happening

La Jolla, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.